Skip to content
Peptigraph home

Kisspeptin-10 Dosage: Doses Studied, Units and Chart

What doses of Kisspeptin-10 have been used in published research, how they convert to syringe units, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGnRH stimulatorUpdated
Doses studied
11 studies
with a stated dose, listed below
Frequency
Varies by study
as used in studies
Half-life
mean elimination half-life 1.3-2.2 hours
subcutaneous (analog MVT-602), in people · Fertility and sterility 2024, PMID 37925096
Vial sizes sold
5 mg, 10 mg

Doses used in published studies

Each dose below is quoted from a study abstract, strongest design first. Animal doses are labelled and do not translate directly to people. None of them is a recommendation.

Doses of Kisspeptin-10 used in published studies
DoseFrequency and routeStudy typeSource
1.25-10.0 nmol/kg/h acute; 150 nmol/h daily 8 h for 12 daysdaily 8 h on, 16 h off · subcutaneous infusion (kisspeptin-10) · 12 daysHuman RCTn = 15European journal of endocrinology 2026, PMID 42549827
0.1 to 3.0 ug MVT-602single dose · subcutaneousHuman RCTFertility and sterility 2024, PMID 37925096
1 nmol/kg/h kisspeptin-54intravenous infusion · 75 minutesHuman RCTn = 40JAMA network open 2022, PMID 36287566
6.4 nmol/kg (kisspeptin-54)twice daily · subcutaneous · 7 daysHuman controlled trialn = 5Clinical endocrinology 2014, PMID 24863252
iv bolus 0.01-3.0 ug/kg; infusion 1.5-4 ug/kg/hintravenous (kisspeptin-10) · infusion up to 22.5 hHuman controlled trialThe Journal of clinical endocrinology and metabolism 2011, PMID 21632807
6.4 nmol/kg (kisspeptin-54)twice daily · subcutaneous · 2 weeksHuman RCTThe Journal of clinical endocrinology and metabolism 2009, PMID 19820030
0.2-6.4 nmol/kg (kisspeptin-54)subcutaneous bolusHuman controlled trialThe Journal of clinical endocrinology and metabolism 2007, PMID 17635940
6.4-12.8 nmol/kg of kisspeptin-54twice daily · subcutaneous · 21 daysHuman uncontrolled trialn = 12Human reproduction 2019, PMID 31820802
1.6 to 12.8 nmol/kg (kisspeptin-54)single injection · subcutaneousHuman uncontrolled trialn = 53The Journal of clinical investigation 2014, PMID 25036713
0.3-10 nmol/injection site of kisspeptin-10intradermalAnimal · mouse (CD1) (not a human result)PloS one 2011, PMID 21347414
20 nmol/rat/day kisspeptin-107 daysAnimal · rat (not a human result)n = 24Cell biochemistry and function 2010, PMID 20517893

Dose to syringe units

For a 10 mg vial mixed with 2 mL of bacteriostatic water (5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.

100 mcg
2 u
250 mcg
5 u
500 mcg
10 u
750 mcg
15 u
1000 mcg
20 u
Use your own vial and water

Before anyone considers it

  • Kisspeptin-10 is not FDA approved for any use.
  • Products sold as research chemicals are not checked by the FDA for identity, purity or dose.
  • Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
  • People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.

Infusion schedules in healthy men

Acute subcutaneous kisspeptin-10 infusions of 1.25-10.0 nmol/kg/h were compared, then continuous 180 nmol/h for 5 days, then daily 8 h infusions at 150 nmol/h for 12 days.[3]

After 5 days of continuous kisspeptin-10, gonadotropin concentrations were similar to vehicle, while daily 8 h infusions over 12 days sustained increases in gonadotropins.[3]

Frequency changed the response in women

In women with hypothalamic amenorrhea given kisspeptin-54 at 6.4 nmol/kg twice daily for 2 wk, LH and FSH rose sharply on the first injection day and the responses were significantly reduced by the 14th.[8]

Twice-weekly kisspeptin-54 produced only partial desensitization, versus complete tolerance with twice-daily dosing, and raised hormones after 8 weeks.[14]

In an IVF study, 53 women received a single subcutaneous kisspeptin-54 injection at 1.6, 3.2, 6.4 or 12.8 nmol/kg after superovulation.[10]

Regulatory

Drugs@FDA lists no kisspeptin product, so the nmol/kg figures above have no labelled counterpart.[15]

Common questions

How many units is 500 mcg of Kisspeptin-10?

It depends on the water added. A 10 mg vial with 2 mL of water gives 5 mg/mL, so 500 mcg is 10 units on a U-100 syringe. Use the calculator for other mixes.

Is Kisspeptin-10 FDA approved?

No. Kisspeptin-10 is not FDA approved for any use.

What is the kisspeptin dosing in studies?

In healthy men, kisspeptin-10 was infused at 150 nmol/h for 8 h daily over 12 days; the kisspeptin-54 studies in women used nmol/kg injections.[3]

Is there a kisspeptin dosage for women?

The women's studies used kisspeptin-54, for example 6.4 nmol/kg twice daily for 2 wk, after which responses were significantly reduced by the 14th injection day.[8]

Is there a kisspeptin 10 dosage for men?

In healthy men, kisspeptin-10 was given as 1.25-10.0 nmol/kg/h acute infusions and as fixed nmol/h infusions over several days.[3]

More on Kisspeptin-10

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.European journal of endocrinology · 2026PMID 42549827Accessed 2 Oct 2026
  4. 4Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.Fertility and sterility · 2024PMID 37925096Accessed 2 Oct 2026
  5. 5Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.JAMA network open · 2022PMID 36287566Accessed 2 Oct 2026
  6. 6Acute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women.Clinical endocrinology · 2014PMID 24863252Accessed 2 Oct 2026
  7. 7Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.The Journal of clinical endocrinology and metabolism · 2011PMID 21632807Accessed 2 Oct 2026
  8. 8Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.The Journal of clinical endocrinology and metabolism · 2009PMID 19820030Accessed 2 Oct 2026
  9. 9Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.The Journal of clinical endocrinology and metabolism · 2007PMID 17635940Accessed 2 Oct 2026
  10. 10Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.The Journal of clinical investigation · 2014PMID 25036713Accessed 2 Oct 2026
  11. 11Direct and indirect effects of kisspeptin on liver oxidant and antioxidant systems in young male rats.Cell biochemistry and function · 2010PMID 20517893Accessed 2 Oct 2026
  12. 12Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.Human reproduction (Oxford, England) · 2019PMID 31820802Accessed 11 Oct 2026
  13. 13The vasoactive potential of kisspeptin-10 in the peripheral vasculature.PloS one · 2011PMID 21347414Accessed 11 Oct 2026
  14. 14Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea.Clinical pharmacology and therapeutics · 2010PMID 20980998Accessed 2 Oct 2026
  15. 15Drugs@FDA (openFDA) search: active ingredient "kisspeptin"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026

Found an error? Report a correction.